Polymyalgia rheumatica: diagnosis, prescribing, and monitoring in general practice

Toby Helliwell1, Samantha Lara Hider, Christian David Mallen

  • 1Arthritis Research UK Primary Care Centre, Primary Care Sciences, Keele University, Keele, Staffordshire. t.helliwell@keele.ac.uk

Abstract

Insights

Management of polymyalgia rheumatica (PMR) in UK primary care shows variation. Improved diagnostic exclusion and prophylaxis for treatment complications are recommended for better patient outcomes in polymyalgia rheumatica (PMR) care.

Area of Science:

  • Rheumatology
  • Primary Care Medicine
  • Clinical Practice Research

Background:

  • Polymyalgia rheumatica (PMR) is a prevalent rheumatological condition in older adults.
  • Diagnosis and management of PMR predominantly occur in UK general practice.
  • Current primary care practices exhibit significant variability and underutilization of diagnostic criteria.

Purpose of the Study:

  • To investigate the diagnostic procedures, treatment strategies, and monitoring practices for PMR patients within UK primary care settings.
  • To identify areas for potential optimization in the primary care management of polymyalgia rheumatica.

Main Methods:

  • A retrospective cohort study design was employed.
  • Data were extracted from linked primary care databases in North Staffordshire.
  • Patient records were identified using Read Codes, with subsequent review of investigations, prescriptions, and consultations.

Main Results:

  • Analysis of 304 patient records revealed documented PMR symptoms in 81.6%.
  • Exclusion of differential diagnoses was documented in only 22.4% of patients.
  • Referral to specialist care occurred in 44.4%, with gastric and osteoporosis prophylaxis rates at 28.0% and 60.2% respectively. Complications included osteoporosis (3.9%) and gastric symptoms (18.4%).

Conclusions:

  • The current management of polymyalgia rheumatica in general practice warrants optimization.
  • Key areas for improvement include rigorous documentation of differential diagnosis exclusion and proactive prophylaxis for treatment-related complications such as osteoporosis and gastric issues.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...